MBX NASDAQ

Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.01 (down more than 99.9%), MBX Biosciences, Inc. Common Stock would be worth roughly what it owes.
Total debt $3.3M against a stock market value of $2.42B.
Distance to default 9.14 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $1.7M (short-term plus half of long-term), stock volatility 76.9%; Altman Z'' 18.59. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.